This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma Law USA
October 8 & 9 2024
The Westin Copley PlaceBoston MA

Jennifer Burdman
Chief Counsel Technology & Therapeutics, Chief IP Officer, and Deputy General Counsel at Valo
Speaker

Profile

Jennifer Burdman serves as the Chief IP Officer and Deputy General Counsel at Valo Health, overseeing the company's IP strategy and advising leadership on IP-related matters. Her tenure has seen significant developments, such as the noted licensing deal with Novo Nordisk and the acquisition of Tara Biosystems, which brought in the Biowire advanced tissue engineering and disease modeling tech. Prior to going in-house, as a trial lawyer, her noteworthy cases included a jury verdict of patent infringement resulting in over $34 million in damages, a jury verdict of willful misappropriation of trade secrets with damages of over $900 million, and the successful defense of a university against a licensee seeking expanded rights of sponsored research and license agreements. She was recognized as one of 2020's "Top 25 Women Leaders in Biotechnology" by The Healthcare Technology Report.

Agenda Sessions

  • Exploring the Risks & Opportunities of AI

    12:00pm